Source: https://www.law.cornell.edu/cfr/text/21/part-20
Timestamp: 2017-12-17 21:43:55
Document Index: 658992604

Matched Legal Cases: ['art 20', '§ 20', '§ 20', '§ 20', '§ 20', '§ 20', '§ 20', '§ 360', 'art 20', 'arts 14', 'arts 10']

CFR › Title 21 › Chapter I › Subchapter A › Part 20
Subpart A - Official Testimony and Information (§§ 20.1 - 20.3)
Subpart B - General Policy (§§ 20.20 - 20.34)
Subpart C - Procedures and Fees (§§ 20.40 - 20.55)
Subpart D - Exemptions (§§ 20.60 - 20.67)
Subpart E - Limitations on Exemptions (§§ 20.80 - 20.91)
Subpart F - Availability of Specific Categories of Records (§§ 20.100 - 20.120)
5 U.S.C. 552; 18 U.S.C. 1905; 19 U.S.C. 2531-2582; 21 U.S.C. 321-393; 42 U.S.C. 241, 242, 242a, 242l, 242n, 243, 262, 263, 263b-263n, 264, 265, 300u-300u-5, 300aa-1.
§ 360aaa...360aaa–6 - Omitted
Title 21 published on 06-Nov-2017 11:24
The following are ALL rules, proposed rules, and notices (chronologically) published in the Federal Register relating to 21 CFR Part 20 after this date.
81 FR 45409 - Removal of Review and Reclassification Procedures for Biological Products Licensed Prior to July 1, 1972; Technical Amendment
FR Doc. 2016-16637
Docket No. FDA-2015-N-2103
This rule is effective July 14, 2016.
21 CFR Parts 14 and 20
The Food and Drug Administration (FDA or Agency) is amending the Agency&apos;s regulations by removing certain regulations that include obsolete references. FDA is taking this action to improve the accuracy of the regulations.
77 FR 50589 - Agreements and Memoranda of Understanding Between the Food and Drug Administration and Other Departments, Agencies, and Organizations
FR Doc. 2012-20610
This final rule makes technical changes that will update a requirement that many of the written agreements and memoranda of understanding (MOUs) between the Food and Drug Administration (FDA) and other departments, Agencies, and organizations be published in the Federal Register . Because we already post and will continue to post our ongoing agreements and MOUs with other departments, Agencies, and organizations on our Web site upon their completion, this requirement is no longer necessary. This final rule, accordingly, eliminates it. We are making these technical changes to conserve Agency time and resources, reduce government paperwork, and eliminate unnecessary Federal Register printing costs while continuing to afford public access to these documents.
77 FR 38173 - Agreements and Memoranda of Understanding Between the Food and Drug Administration and Other Departments, Agencies, and Organizations; Withdrawal
FR Doc. 2012-15713
The direct final rule published at 77 FR 16923, March 23, 2012, is withdrawn, effective June 27, 2012.
The Food and Drug Administration (FDA) published in the Federal Register of March 23, 2012 (77 FR 16923), a direct final rule making technical changes to update a requirement that many of its written agreements and memoranda of understanding with other departments, Agencies, and organizations be published in the Federal Register. The comment period closed June 6, 2012. FDA is withdrawing the direct final rule because the Agency received significant adverse comment.
77 FR 16923 - Agreements and Memoranda of Understanding Between the Food and Drug Administration and Other Departments, Agencies, and Organizations
FR Doc. 2012-6967
This rule is effective August 6, 2012. Submit either electronic or written comments on or before June 6, 2012. If we receive no significant adverse comments within the specified comment period, we will publish a document confirming the effective date of the final rule in the Federal Register within 30 days after the comment period on this direct final rule ends. If timely significant adverse comments are received, the Agency will publish a document in the Federal Register withdrawing this direct final rule before its effective date.
This direct final rule makes technical changes that will update a requirement that many of our written agreements and memoranda of understanding (MOUs) with other departments, Agencies, and organizations be published in the Federal Register . Because we already post and will continue to post our ongoing agreements and MOUs with other departments, Agencies, and organizations on our Web site upon their completion, this requirement is no longer necessary. This direct final rule, accordingly, eliminates it. We are making these technical changes to conserve Agency time and resources, reduce government paperwork, and eliminate unnecessary Federal Register printing costs while continuing to afford public access to these documents. We are proceeding in accordance with our direct final rule procedures. We are publishing a companion proposed rule under our usual procedure for notice-and-comment rulemaking to provide a procedural framework to finalize the rule in the event we receive any significant adverse comments and withdraw this direct final rule. The companion proposed rule and this direct final rule are substantively identical.
FR Doc. 2012-6969
We are publishing this companion proposed rule to the direct final rule on “Agreements and Memoranda of Understanding Between the Food and Drug Administration and Other Departments, Agencies, and Organizations,” which makes technical changes intended to update a requirement that many of these agreements and memoranda of understanding (MOUs) be published in the Federal Register . Because we already post and will continue to post our ongoing agreements and MOUs with other departments, Agencies, and organizations on our Web site upon their completion, this requirement is no longer necessary. This proposed rule, accordingly, would eliminate it. We are proposing these technical changes to conserve Agency time and resources, reduce government paperwork, and eliminate unnecessary Federal Register printing costs while continuing to afford public access to these documents.
77 FR 3653 - Import Tolerances for Residues of Unapproved New Animal Drugs in Food
FR Doc. 2012-1430
RIN 0910-AF78
Docket No. 2001N-0284)
21 CFR Parts 10, 20, 25, and 510